Chugai Seiyaku Kabushiki Kaisha

Dic Corporation

Dainippon Ink and Chemicals, Incorporated

Sumitomo Chemical Company, Limited

Dai Nippon Printing Co., Ltd.

Kuraray Co., Ltd.

Toppan Printing Co., Ltd.

Jsr Corporation

Konica-Minolta Holdings, Inc.

Sumitomo Bakelite Company Limited

Nec Corporation

Toray Industries, Inc.

Hitachi Chemical Company, Ltd.

Kawamura Inst. of Chemical Res.

Yoshiyuki Ono

Hirotaka Kashiwagi

David Mark Wallace

Yoshiaki Watanabe

Mi Chen

Yasuhiro Kuwana

Jie Fei Cheng

Thomas Arrhenius

Sovouthy Tith

Yoshinori Iwashita

Hiroshi Hasebe

Hidetoshi Nakata

Jouji Kawamura

Mika Yamamoto

Kunihiko Kotani

Hiroyuki Takeda

Koichi Endou

Ken Sumiyoshi

Hiroshi Sakamoto

Kazushige Takechi

Noboru Oshima

Akimitsu Tsukuda

Ichiro Fujieda

Takashi Emura

Atsushi Kumano

Motoyuki Suzuki

Katsuya Fujisawa

Hisatomo Yonehara

Nobuhiro Oikawa

Takanori Anazawa

Toshimasa Eguchi

Hatsuo Kawada

Yoshiki Matsuoka

Kazuo Genda

Toshiya Ito

Kenji Morikami

Nobuya Ishii

Tokuo Ikari

Noriyuki Furuichi

Shigenori Yamaoka

Tatsumi Takahashi

Norimasa Sekine

Kazutomo Kinoshita

Yasuo Tsuruoka

Yasuharu Kato

Kohsuke Asoh

WooSang Hong

MinJeong Park

Naoki Okamoto

Kazunori Maruyama

Isa Nishiyama

Yasuyuki Suzuki

Katsuji Takahashi

Atsushi Kimbara

Kenichi Nomura

Eisaku Mizuguchi

Tadakatsu Takahashi

Nobuyuki Hori

Hitoshi Hayakawa

Yasuyuki Watanabe

Kiyotaka Kawashima

Tsuyoshi Haneishi

Toru Ishii

Kazutaka Tachibana

Minjeong Park

Yoshihito Ohtake

Kazuki Shimizu

Takeo Harada

Yoshihisa Murata

Shota Tanaka

Naoshi Horiba

Jyoji Kawamura

Takashi Furusawa

Ikuko Ogawa

Yoshinari Santo

Kazuo Hasumi

Mitsuaki Ide

Yasuhiro Ichida

Shuichi Ohtomo

Woosang Hong

A retardation plate is formed by laminating at least two retardation plates of a retardation plate 1 and a retardation plate 2, in which at least one of the retardation plate 1 and the retardation plate 2 is formed of a polymer of a polymerizable liquid crystal composition. It is possible to provide a retardation plate imparting a phase difference of &#xbc; wavelength over a wide wavelength region, a circularly polarizing plate having excellent anti-reflection performance over a wide wavelength region, and a display element or a light-emitting element having excellent visibility.

Retardation plate and circularly polarizing plate

There is provided a compound containing a mesogenic group, which includes a silicon compound at a low concentration, a polymerizable compound containing the mesogenic group, a mixture and a composition using these compounds, a polymerizable mixture having the polymerizable compound, and a polymer, an optically anisotropic body, and a phase difference film using the polymerizable composition. It is possible to obtain the optically anisotropic body and the phase difference film having satisfactory scratch resistance and adhesion, by using the polymerizable composition composed of the compound containing a mesogenic group, which includes a silicon compound at a low concentration.

Compound containing mesogenic group, and mixture, composition, and optically anisotropic body using said compound

The present invention provides a method for producing a polymerizable liquid crystal composition which produces films being uncolored and having no cissing and good alignment when applied to a substrate, and also provides a polymerizable liquid crystal composition produced by the method and an optically anisotropic body using the polymerizable liquid crystal composition. Specifically, the present invention provides a method for producing a polymerizable liquid crystal composition, the method comprising a step (I) of preparing a polymerizable solution by mixing at least one polymerizable compound having at least one polymerizable functional group and one or two or more organic solvents and heating and stirring the resultant mixture; and a step (II) of mixing the polymerizable solution with a polymerization initiator, and also provides a polymerizable liquid crystal composition produced by the method and an optically anisotropic body using the polymerizable liquid crystal composition.

Production method for polymerizable liquid crystal composition

The present invention relates to a liquid crystal display that incorporates a particular liquid crystal composition and a sealant in which a cured form of a particular curable resin composition is used. The present invention provides a liquid crystal display that prevents reduced voltage holding ratio (VHR) and increased ionic density (ID) in the liquid crystal layer and solves the problems of display defects such as voids, alignment irregularities, and image-sticking. Liquid crystal displays according to the present invention, featuring the ability to prevent reduced voltage holding ratio (VHR) in the liquid crystal layer and reduce the occurrence of display defects such as alignment irregularities and image-sticking, are useful particularly to liquid crystal displays in the IPS and FFS modes for active matrix drive and applicable to liquid crystal displays of equipment such as liquid crystal TVs, monitors, mobile phones, and smartphones.

Liquid crystal display

The present invention relates to a liquid crystal display device including a specific liquid crystal composition and a sealant in which a cured product of a specific curable resin composition is used. The present invention provides a liquid crystal display device which prevents a decrease in the voltage holding ratio (VHR) of the liquid crystal layer and which enables elimination of problematic defective display such as voids, uneven alignment, and screen burn-in. Since the liquid crystal display device of the present invention prevents a decrease in the voltage holding ratio (VHR) of the liquid crystal layer and enables a reduction in defective display such as uneven alignment and screen burn-in, it is particularly useful for active-matrix liquid crystal display devices of a VA mode and PSVA mode and can be applied to liquid crystal display apparatuses such as liquid crystal TVs, monitors, mobile phones, and smartphones.

Liquid crystal display device

A polymerizable composition solution that has good storage stability and allows a polymerizable compound in the polymerizable composition to be aligned well with no defects after application to a base and removal of a solvent by a drying process and also an optically anisotropic body that includes the solution and has good alignment without any defects. A solution containing a polymerizable composition and an organic solvent, wherein the polymerizable composition contains 90 mass % or more of a polymerizable compound intramolecularly having a 2-methyl-1,4-phenylene group as represented by general formula (1) and an optically anisotropic body including the solution.

Polymerizable composition solution and optically anisotropic body including the same

The present invention relates to a liquid crystal display device including a specific liquid crystal composition and a sealant containing the cured product of a specific curable resin composition. The present invention provides a liquid crystal display device which prevents a decrease in the voltage holding ratio (VHR) of the liquid crystal layer and an increase in ion density (ID) and which enables elimination of problematic defective display such as voids, uneven alignment, and screen burn-in. Since the liquid crystal display device of the present invention prevents a decrease in the voltage holding ratio (VHR) of the liquid crystal layer and enables a reduction in defective display such as uneven alignment and screen burn-in, it is particularly useful for active-matrix liquid crystal display devices of an IPS mode and FFS mode and can be applied to liquid crystal display apparatuses such as liquid crystal TVs, monitors, mobile phones, and smartphones.

The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification comprising the compound as an active ingredient, and a method for prevention and/or treatment.

Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same

A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder: 

Tetracyclic compound

An object of the present invention is to provide a process for synthesizing a vitamin D compound by simple procedures at lower costs. The present invention provides a process for preparing a vitamin D compound and an intermediate thereof, comprising the step of: (a) mixing a ketone or aldehyde, a Wittig reagent, and a base; or (b) mixing a ketone or aldehyde and a Wittig reagent, and then adding a base to the resulting mixture.

Process for the synthesis of vitamin D compounds and intermediates for the synthesis of the compounds

A conventional liquid crystal display comprises a number of components, so that a manufacturing cost cannot be reduced. Furthermore, a large-area substrate has problems in shipping. According to this invention, a liquid-crystal panel is prepared by forming individual optically functional films, a TFT device and a light-emitting device on a long thin film and then laminating the film by a transfer process. A base film to be a substrate in a liquid-crystal panel preferably has a thickness of 10 &#x3bc;m to 200 &#x3bc;m, a curvature radius of 40 mm or less as a measure of flexibility and a coefficient of thermal expansion of 50 ppm/&#xb0; C. or less. Furthermore, it more preferably gives a variation of &#xb1;5% or less in mechanical and optical properties to a thermal history at 200&#xb0; C.

Light-condensing film, liquid-crystal panel and backlight as well as manufacturing process for light-condensing film

An optical filmof the present invention includes a plurality of optically anisotropic layerswhich are laminated, wherein the optically anisotropic layer including: a photoalignment layer (A), in which a liquid crystal aligning capability has been generated by means of photoirradiation; and a polymer layer (B), which contains a liquid crystal compound that has a polymerizable group, and which is obtained by polymerization in a state where it has been aligned by the photoalignment layer (A), wherein the photoalignment layer (A)and the polymer layer (B)are bonded by covalent bonding. The plurality of optically anisotropic layersmay be an optically anisotropic layerhaving a function of a one-half wavelength plate, and an optically anisotropic layerhaving a function of a one-quarter wavelength plate.

Optical film, elliptically polarizing plate, circularly polarizing plate, liquid  crystal display element, and method of producing optical film

Novel compounds composition capable of inhibiting TNF&#x3b1; and having antiimmunionflammatory and autoimmune properties useful in a pharmaceutical composition, such as for a drug containing this as an active ingredient; and a therapeutic method with the use of these novel compounds.

Coumarin derivatives useful as TNF&#x3b1; inhibitors

The present invention provides a compound represented by the following general formula (I): or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing such a compound, and the like. The compound or a pharmaceutically acceptable salt thereof, the pharmaceutical composition containing such a compound, or the like is useful as a medicine or the like for therapy of benign prostatic hyperplasia, cancer, osteoporosis, psoriasis, secondary hyperparathyroidism, chronic glomerulonephritis, lupus nephritis and/or diabetic nephropathy and the like.

Vitamin D-like compound

Growing community of inventors

Kita-adachi-gun, Japan

Yoshiyuki Ono